Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You and Your Team.

Learn More →

Cutaneous Malignant Melanoma After Immunosuppressive Therapy

Cutaneous Malignant Melanoma After Immunosuppressive Therapy Abstract • Malignant neoplasm after immunosuppressive therapy is a well-known entity. Though a considerable number of such lesions are cutaneous in origin, melanoma has rarely been reported. In this communication, six such melanoma cases are reported. (Arch Surg 115:322-323, 1980) References 1. Harris CC: Malignancy during methotrexate and steroid-therapy for psoriasis . Arch Dermatol 103:501-504, 1971.Crossref 2. Marshall V: Premalignant and malignant skin tumor in immunosuppressed patients . Transplantation 17:272-274, 1974.Crossref 3. Mariza JC: Skin cancer in immunosuppressed patients . JAMA 237:1977. 4. Manny N, Rosenman E, Benbassat J: Hazard of immunosuppressive therapy . Br Med J 2:291, 1972.Crossref 5. Brady RS, Schottenfeld D, Reid A: Multiple primary cancer risk after therapy for Hodgkin's disease . Cancer 40:1917-1926, 1977.Crossref 6. Neufeld H, Weineman BH, Kemel S: Secondary malignant neoplasms in patients with Hodgkin's disease . JAMA 239:2470-2471, 1978.Crossref 7. Retaz EP, Shimacha K: Secondary malignant neoplasms in Hodgkin's disease . JAMA 240:1337, 1978.Crossref http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Archives of Surgery American Medical Association

Cutaneous Malignant Melanoma After Immunosuppressive Therapy

Loading next page...
 
/lp/american-medical-association/cutaneous-malignant-melanoma-after-immunosuppressive-therapy-NJegj3C0cW
Publisher
American Medical Association
Copyright
Copyright © 1980 American Medical Association. All Rights Reserved.
ISSN
0004-0010
eISSN
1538-3644
DOI
10.1001/archsurg.1980.01380030068015
Publisher site
See Article on Publisher Site

Abstract

Abstract • Malignant neoplasm after immunosuppressive therapy is a well-known entity. Though a considerable number of such lesions are cutaneous in origin, melanoma has rarely been reported. In this communication, six such melanoma cases are reported. (Arch Surg 115:322-323, 1980) References 1. Harris CC: Malignancy during methotrexate and steroid-therapy for psoriasis . Arch Dermatol 103:501-504, 1971.Crossref 2. Marshall V: Premalignant and malignant skin tumor in immunosuppressed patients . Transplantation 17:272-274, 1974.Crossref 3. Mariza JC: Skin cancer in immunosuppressed patients . JAMA 237:1977. 4. Manny N, Rosenman E, Benbassat J: Hazard of immunosuppressive therapy . Br Med J 2:291, 1972.Crossref 5. Brady RS, Schottenfeld D, Reid A: Multiple primary cancer risk after therapy for Hodgkin's disease . Cancer 40:1917-1926, 1977.Crossref 6. Neufeld H, Weineman BH, Kemel S: Secondary malignant neoplasms in patients with Hodgkin's disease . JAMA 239:2470-2471, 1978.Crossref 7. Retaz EP, Shimacha K: Secondary malignant neoplasms in Hodgkin's disease . JAMA 240:1337, 1978.Crossref

Journal

Archives of SurgeryAmerican Medical Association

Published: Mar 1, 1980

References